2022-11-012023-10-312023-10-31false13679522DM HEALTHCARE LIMITED2024-07-30iso4217:GBPxbrli:pure136795222022-11-01136795222023-10-31136795222022-11-012023-10-31136795222021-10-14136795222022-10-31136795222021-10-142022-10-3113679522bus:SmallEntities2022-11-012023-10-3113679522bus:AuditExempt-NoAccountantsReport2022-11-012023-10-3113679522bus:FullAccounts2022-11-012023-10-3113679522bus:PrivateLimitedCompanyLtd2022-11-012023-10-3113679522core:WithinOneYear2023-10-3113679522core:AfterOneYear2023-10-3113679522core:WithinOneYear2022-10-3113679522core:AfterOneYear2022-10-3113679522core:ShareCapital2023-10-3113679522core:SharePremium2023-10-3113679522core:RevaluationReserve2023-10-3113679522core:OtherReservesSubtotal2023-10-3113679522core:RetainedEarningsAccumulatedLosses2023-10-3113679522core:ShareCapital2022-10-3113679522core:SharePremium2022-10-3113679522core:RevaluationReserve2022-10-3113679522core:OtherReservesSubtotal2022-10-3113679522core:RetainedEarningsAccumulatedLosses2022-10-3113679522core:LandBuildings2023-10-3113679522core:PlantMachinery2023-10-3113679522core:Vehicles2023-10-3113679522core:FurnitureFittings2023-10-3113679522core:OfficeEquipment2023-10-3113679522core:NetGoodwill2023-10-3113679522core:IntangibleAssetsOtherThanGoodwill2023-10-3113679522core:ListedExchangeTraded2023-10-3113679522core:UnlistedNon-exchangeTraded2023-10-3113679522core:LandBuildings2022-10-3113679522core:PlantMachinery2022-10-3113679522core:Vehicles2022-10-3113679522core:FurnitureFittings2022-10-3113679522core:OfficeEquipment2022-10-3113679522core:NetGoodwill2022-10-3113679522core:IntangibleAssetsOtherThanGoodwill2022-10-3113679522core:ListedExchangeTraded2022-10-3113679522core:UnlistedNon-exchangeTraded2022-10-3113679522core:LandBuildings2022-11-012023-10-3113679522core:PlantMachinery2022-11-012023-10-3113679522core:Vehicles2022-11-012023-10-3113679522core:FurnitureFittings2022-11-012023-10-3113679522core:OfficeEquipment2022-11-012023-10-3113679522core:NetGoodwill2022-11-012023-10-3113679522core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3113679522core:ListedExchangeTraded2022-11-012023-10-3113679522core:UnlistedNon-exchangeTraded2022-11-012023-10-3113679522core:MoreThanFiveYears2022-11-012023-10-3113679522core:Non-currentFinancialInstruments2023-10-3113679522core:Non-currentFinancialInstruments2022-10-3113679522dpl:CostSales2022-11-012023-10-3113679522dpl:DistributionCosts2022-11-012023-10-3113679522core:LandBuildings2022-11-012023-10-3113679522core:PlantMachinery2022-11-012023-10-3113679522core:Vehicles2022-11-012023-10-3113679522core:FurnitureFittings2022-11-012023-10-3113679522core:OfficeEquipment2022-11-012023-10-3113679522dpl:AdministrativeExpenses2022-11-012023-10-3113679522core:NetGoodwill2022-11-012023-10-3113679522core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3113679522dpl:GroupUndertakings2022-11-012023-10-3113679522dpl:ParticipatingInterests2022-11-012023-10-3113679522dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-012023-10-3113679522core:ListedExchangeTraded2022-11-012023-10-3113679522dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-012023-10-3113679522core:UnlistedNon-exchangeTraded2022-11-012023-10-3113679522dpl:CostSales2021-10-142022-10-3113679522dpl:DistributionCosts2021-10-142022-10-3113679522core:LandBuildings2021-10-142022-10-3113679522core:PlantMachinery2021-10-142022-10-3113679522core:Vehicles2021-10-142022-10-3113679522core:FurnitureFittings2021-10-142022-10-3113679522core:OfficeEquipment2021-10-142022-10-3113679522dpl:AdministrativeExpenses2021-10-142022-10-3113679522core:NetGoodwill2021-10-142022-10-3113679522core:IntangibleAssetsOtherThanGoodwill2021-10-142022-10-3113679522dpl:GroupUndertakings2021-10-142022-10-3113679522dpl:ParticipatingInterests2021-10-142022-10-3113679522dpl:GroupUndertakingscore:ListedExchangeTraded2021-10-142022-10-3113679522core:ListedExchangeTraded2021-10-142022-10-3113679522dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-10-142022-10-3113679522core:UnlistedNon-exchangeTraded2021-10-142022-10-3113679522core:NetGoodwill2023-10-3113679522core:IntangibleAssetsOtherThanGoodwill2023-10-3113679522core:LandBuildings2023-10-3113679522core:PlantMachinery2023-10-3113679522core:Vehicles2023-10-3113679522core:FurnitureFittings2023-10-3113679522core:OfficeEquipment2023-10-3113679522core:AfterOneYear2023-10-3113679522core:WithinOneYear2023-10-3113679522core:ListedExchangeTraded2023-10-3113679522core:UnlistedNon-exchangeTraded2023-10-3113679522core:ShareCapital2023-10-3113679522core:SharePremium2023-10-3113679522core:RevaluationReserve2023-10-3113679522core:OtherReservesSubtotal2023-10-3113679522core:RetainedEarningsAccumulatedLosses2023-10-3113679522core:NetGoodwill2022-10-3113679522core:IntangibleAssetsOtherThanGoodwill2022-10-3113679522core:LandBuildings2022-10-3113679522core:PlantMachinery2022-10-3113679522core:Vehicles2022-10-3113679522core:FurnitureFittings2022-10-3113679522core:OfficeEquipment2022-10-3113679522core:AfterOneYear2022-10-3113679522core:WithinOneYear2022-10-3113679522core:ListedExchangeTraded2022-10-3113679522core:UnlistedNon-exchangeTraded2022-10-3113679522core:ShareCapital2022-10-3113679522core:SharePremium2022-10-3113679522core:RevaluationReserve2022-10-3113679522core:OtherReservesSubtotal2022-10-3113679522core:RetainedEarningsAccumulatedLosses2022-10-3113679522core:NetGoodwill2021-10-1413679522core:IntangibleAssetsOtherThanGoodwill2021-10-1413679522core:LandBuildings2021-10-1413679522core:PlantMachinery2021-10-1413679522core:Vehicles2021-10-1413679522core:FurnitureFittings2021-10-1413679522core:OfficeEquipment2021-10-1413679522core:AfterOneYear2021-10-1413679522core:WithinOneYear2021-10-1413679522core:ListedExchangeTraded2021-10-1413679522core:UnlistedNon-exchangeTraded2021-10-1413679522core:ShareCapital2021-10-1413679522core:SharePremium2021-10-1413679522core:RevaluationReserve2021-10-1413679522core:OtherReservesSubtotal2021-10-1413679522core:RetainedEarningsAccumulatedLosses2021-10-1413679522core:AfterOneYear2022-11-012023-10-3113679522core:WithinOneYear2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:CostValuation2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3113679522core:Non-currentFinancialInstrumentscore:CostValuation2023-10-3113679522core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-3113679522core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-3113679522core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-3113679522core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-3113679522core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-3113679522core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-3113679522core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-3113679522core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-3113679522core:Non-currentFinancialInstrumentscore:CostValuation2022-10-3113679522core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-10-3113679522core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-10-3113679522core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-10-3113679522core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-10-3113679522core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-10-3113679522core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-10-3113679522core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-10-3113679522core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-10-3113679522bus:Director12022-11-012023-10-3113679522bus:Director22022-11-012023-10-31

DM HEALTHCARE LIMITED

Registered Number
13679522
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2023

DM HEALTHCARE LIMITED
Company Information
for the year from 1 November 2022 to 31 October 2023

Directors

AHMED, Mobeen
KUMAR, Deepak

Registered Address

Needham Market Dental Practice 56 High Street
Needham Market
Ipswich
IP6 8AP

Registered Number

13679522 (England and Wales)
DM HEALTHCARE LIMITED
Balance Sheet as at
31 October 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Investment property3651,863437,094
651,863437,094
Current assets
Debtors4-100
Cash at bank and on hand41192
411192
Creditors amounts falling due within one year5(608,829)(419,021)
Net current assets (liabilities)(608,418)(418,829)
Total assets less current liabilities43,44518,265
Net assets43,44518,265
Capital and reserves
Called up share capital100100
Profit and loss account43,34518,165
Shareholders' funds43,44518,265
The financial statements were approved and authorised for issue by the Board of Directors on 30 July 2024, and are signed on its behalf by:
AHMED, Mobeen
Director
KUMAR, Deepak
Director

Registered Company No. 13679522
DM HEALTHCARE LIMITED
Notes to the Financial Statements
for the year ended 31 October 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention modified to include investment properties and certain financial instruments at fair value.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the rent received or receivable.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Investment property
Investment property which is property held to earn rentals and/or for capital appreciation is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. The surplus or deficit on revaluation is recognised in profit and loss account.
Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Basic financial liabilities Basic financial liabilities, including creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortized cost using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20232022
Average number of employees during the year22
3.Investment property
Investment properties above have been shown at the fair value which is valued by the director.

£
Fair value at 01 November 22437,094
Additions214,769
At 31 October 23651,863
4.Debtors: amounts due within one year

2023

2022

££
Other debtors-100
Total-100
5.Creditors: amounts due within one year

2023

2022

££
Taxation and social security-4,261
Other creditors607,029413,860
Accrued liabilities and deferred income1,800900
Total608,829419,021
6.Related party transactions
Included in other creditors falling due within one year is an amount of £118,617 (2022 : £118,617) due to DK Nankani Ltd, a company connected to the director, Deepak Kumar. Included in other creditors falling due within one year is an amount of £200,571 (2022 : £200,571) due to Mobeen Holdings Ltd, a company connected to the director, Mobeen Ahmed. Included in other creditors at the year end is an amount of £851 (2022 : £130) due to the director, Deepak Kumar. Included in other creditors at the year end is an amount of £221 (2022 : £NIL) due to the director, Mobeen Ahmed. Included in other creditors at the year end is an amount of £223,768 (2022 : £31,542) due to the Needham Market Dental Practice, a partnership related to directors. During the year, the company received rent of £22,000 (2022 : £Nil) from the partnership.